Alvotech Finds A New Omalizumab Partner In Kashiv

Pair’s Alliance On Xolair Biosimilar Follows Terminated Collaboration With BiosanaPharma

 
• By Dave Wallace

After earlier this year revealing that it had dropped a collaboration with BiosanaPharma on a biosimilar omalizumab rival to Xolair, Alvotech has now announced a fresh licensing deal for development and commercialization of a version from Kashiv BioSciences.

Red and green Enter and Exit sign icons
Alvotech has entered a new omalizumab partnership after exiting a previous deal • Source: Shutterstock

More from Biosimilars

More from Products